Hepatitis C team care for people in supportive housing
Part of Digestive system, Infections clinical trials.
This study tests a team-based approach — a pharmacist, doctor, and patient navigator working together — to help people living in permanent supportive housing get hepatitis C care. If you have hepatitis C and live in DESC housing, the study will check how well this team helps you through treatment over 2 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You live in a DESC permanent supportive housing building
- You have tested positive for hepatitis C (antibody or viral load test)
- You are not already taking hepatitis C medication
- You can give permission for researchers to access your pharmacy and medical records
- You are not planning to leave the Seattle area within the next 2 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a booster session of a partner navigation program that helps people who inject drugs stay engaged in healthcare after completing hepatitis C treatment. You and your injecting partner would receive extra support to keep you both healthy.
This study tests a pill combination (sofosbuvir/velpatasvir) to cure hepatitis C. It aims to make treatment simple and accessible, and you can join even if you've had treatment before (if it failed or you got reinfected).
This study offers a once-daily pill (Epclusa) to treat hepatitis C for people in jail who have never taken HCV medicine before. The goal is to see if starting treatment while incarcerated and continuing after release can cure the infection.
This study offers a one-stop approach to testing and treating hepatitis C during a single emergency room visit. If you test positive, you may receive treatment right away, potentially avoiding extra appointments and helping you get cured faster.
This study tests a simple treatment for Hepatitis C in people experiencing unsheltered homelessness. It aims to help those who are receiving street medicine care and have not been treated before.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
Hear when a new HEPATITIS C (HCV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.